4
Participants
Start Date
February 28, 2007
Primary Completion Date
August 31, 2008
Study Completion Date
August 31, 2008
Insulin Aspart versus Insulin Lispro
Subjects will be randomly assigned to insulin aspart versus insulin lispro via random number generation. Half of the patients will begin with insulin aspart, and then will be crossed over to insulin lispro. The insulin sequence will be reversed for the other half of the patients.
Insulin Lispro versus Insulin Aspart
Subjects will be randomly assigned to insulin lispro versus insulin aspart via random number generation. Half of the patients will begin with insulin lispro, and then will be crossed over to insulin aspart. The insulin sequence will be reversed for the other half of the patients.
Joslin Diabetes Center, Boston
Collaborators (1)
Novo Nordisk A/S
INDUSTRY
Joslin Diabetes Center
OTHER